Antithrombin reduces compression-induced spinal cord injury in rats

Journal of Neurotrauma

Volumn 21, Issue 12, 2004, Pages 1818-1830

  Taoka, Yuji ^a,b   Okajima, Kenji ^a   Uchiba, Mitsuhiro ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b TOKUSHIMA PREFECTURAL CENTRAL HOSPITAL   (Japan)

Author keywords

Antithrombin; Motor disturbances; Neutrophil activation; PGI2; Spinal cord injury; Tumor necrosis factor

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; ANTITHROMBIN; ILOPROST; INDOMETACIN; PROSTACYCLIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENDOTHELIUM CELL; GENETIC TRANSCRIPTION; LEUKOCYTE ACTIVATION; MALE; MOTONEURON; MOTOR DYSFUNCTION; NEUROPHARMACOLOGY; NONHUMAN; PROSTAGLANDIN RELEASE; PROTEIN SECRETION; RAT; SPINAL CORD COMPRESSION; SPINAL CORD HEMORRHAGE; SPINAL CORD INJURY; TISSUE INJURY;

6-KETOPROSTAGLANDIN F1 ALPHA; AMINO ACID CHLOROMETHYL KETONES; ANIMALS; ANTITHROMBINS; ENDOTHELIAL CELLS; EPOPROSTENOL; FACTOR XA; INDOMETHACIN; MALE; MOTOR ACTIVITY; PEPTIDE FRAGMENTS; PEROXIDASE; RATS; RATS, WISTAR; RNA, MESSENGER; SPINAL CORD COMPRESSION; THROMBIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 9744222929     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.2004.21.1818     Document Type: Article

References (51)

1. BAJAJ, S.P., RAPAPORT, S.I., and PRODANOS, C.A. (1981). A simplified procedure for purification of human prothrombin, factor IX and factor X. Prep. Biochem. 11, 397-412.
2. BARTHOLDI, D., and SCWAB, M.E. (1997). Expression of pro-inflammatory cytokine and chemokine mRNA upon experimental spinal cord injury in mouse, an in situ hybridization study. Eur. J. Neurosci. 9, 1422-1438.
3. BIERHAUS, A., ZHANG, Y., DENG, Y., et al. (1995). Mechanism of the tumor necrosis factor alpha-mediated induction of endothelial tissue factor. J. Biol. Chem. 270, 26419-26432.
4. BRACKEN, M.B., SHEPARD, M.J., COLLINS, W.F., et al. (1990). A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. N. Engl. J. Med. 322, 1405-1411.
5. BRENNAN, S.O., GEORGE, P.M., and JORDAN, R.E. (1987). Physiological variant of antithrombin-III lacks carbohydrate side chain at Asn-135. FEES Lett. 219, 431-436.
6. CHOMCZNSKI, P., and SACCHI, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
7. D'ACQUISTO, F., SAUTEBIN, L., IUVONE, T., DI ROSA, M., and CARNUCCIO, R. (1998). Prostaglandins prevent inducible nitric oxide synthase protein expression by inhibiting nuclear factor-kappaB activation in J774 macrophages. FEES Lett. 440, 76-80.
8. DUNZENDORFER, S., KANEIDER, N., RABENSTEINER, et al. (2001). Cell-surface heparan sulfate proteoglycan-mediated regulation of human neutrophil migration by the serpin antithrombin III. Blood 97, 1079-1085.
9. FOURRIER, F., CHOPIN C., HUART, J.J., RUNGE, L, CARON, C., and GOUDEMAND, J. (1993). Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation. Chest 104, 882-888.
10. GRANT, S.M., and GOA, K.L. (1992). Iloprost. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peripheral vascular disease, myocardial ischemia and extracorporeal circulation procedures. Drugs 43, 889-924.
11. GRIFFITH, M.J. (1979). Kinetic analysis of the heparin-enhanced antithrombin III/thrombin reaction. J. Biol. Chem. 254, 12044-12049.
12. GUTH, L., ZHANG, Z., and ROBERTS, E. (1994a). Key role for pregnenolone in combination therapy that promotes recovery after spinal cord injury. Proc. Natl. Acad. Sci. USA 91, 12308-12312.
13. GUTH, L., ZHANG, Z., DIPROSPERO, N.A., JOUBIN, K., and FITCH, M.T. (1994b). Spinal cord injury in the rat: treatment with bacterial lipopolysaccharide and indomethacin enhances cellular repair and locomotor function. Exp. Neurol. 126, 76-87.
14. GUVEN, M.B., CIRAK, B., YUCEER, N., and OZVEREN, F. (1999). Is indomethacin harmful in spinal cord injury treatment? Pediatr. Neurosurg. 31, 189-193.
15. HARADA, N., OKAJIMA, K., KUSHIMOTO, S., ISOBE, H., and TANAKA, K. (1999). Antithrombin reduces ischemia/reperfusion injury of rat liver by increasing the hepatic level of prostacyclin. Blood 93, 157-164.
16. HIROSE, K., OKAJIMA, K., TAOKA, Y., et al. (2000). Activated protein C reduces the ischemia-induced spinal cord injury in rats by inhibiting neutrophil activation. Ann. Surg. 232, 272-280.
17. KARP, G.I., MARCUM, J.A., and ROSENBERG, R.D. (1984). The role of tryptophan residues in heparin-antithrombin interactions. Arch. Biochim. Biophys. 233, 712-720.
18. KLEBANOFF, S.J., VADAS, M.A., and HARLAN, J.M. (1986). Stimulation of neutrophils by tumor necrosis factor. J. Immunol. 136, 4220-4225.
19. KUNKEL-BAGDEN, E., and BREGMAN, B.S. (1993). Methods to assess the development and recovery of locomotor function after spinal cord injury in rats. Exp. Neurol. 119, 153-164.
20. LIU, S., ADCOCK, I.M., OLD, R.V., BARNES, P.J., and EVANS, T.W. (1993). Lipopolysaccharide treatment in vivo induces wide-spread tissue expression of inducible nitric oxide synthase mRNA. Biochem. Biophys. Res. Commun. 196, 1208-1213.
21. MITCHELL, J.A., AKARASEREENONT, P., THIEMERMANN, C., FLOWER, R.J., and VANE, J.R. (1994). Selectivity of non-steroidal anti-inflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc. Natl. Acad. Sci. USA 90, 11693-11697.
22. 2 and LTC4 in experimental spinal cord injuries. Paraplegia 32, 524-530.
23. MIZUTANI, A., OKAJIMA, K., UCHIBA, M., et al. (2003). Antithrombin reduces ischemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation through promotion of prostacyclin production. Blood 101, 3029-3036.
24. MONCADA, S., and VANE, J.R. (1978). Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin. Pharmacol. Rev. 30, 293-331.
25. MORITA, T., and JACKSON, C.M. (1986). Localization of the structural difference between bovine blood coagulation factors X1 and X2 to tyrosine 18 in the activation peptide. J. Biol. Chem. 261, 4008-4014.
26. NARUO, S., OKAJIMA, K., TAOKA, Y., et al. (2003). Prostaglandin E1 reduces compression trauma-induced spinal cord injury in rats mainly by inhibiting neutrophil activation. J. Neurotrauma 20, 221-228.
27. NESHEIM, M.E., KETTNER, C., SHAW, E., and MANN, K.G. (1981). Cofactor dependence of factor Xa incorporation into the prothrombinase complex. J. Biol. Chem. 256, 6537-6540.
28. NYSTROM, B., and BERGLUND, J.E. (1988). Spinal cord restitution following compression injuries in rats. Acta Neurol. Scand. 78, 467-472.
29. O'BRIEN, D.P. (1989). The molecular biology and biochemistry of tissue factor. Baillieres Clin. Haematol. 2, 801-820.
30. OELSCHLAGER, C., ROMISCH, J., STAUBITZ, A., et al. (2002). Antithrombin III inhibits nuclear factor kappaB activation in human monocytes and vascular endothelial cells. Blood 99, 4015-4020.
31. OH-ISHI, S., UTSUNOMIYA, I., YAMANMOTO, T., KOMURO, Y., and HARA, Y. (1996). Effects of prostaglandins and cyclic AMP on cytokine production in rat leukocytes. Eur. J. Pharmacol. 300, 255-259.
32. RIVLIN, A.S., and TATOR, C.H. (1977). Objective clinical assessment of motor function after experimental spinal cord injury in the rat. J. Neurosurg. 47, 577-581.
33. ROSENBERG, R.D. (1989). Biochemistry of heparin antithrombin interactions, and physiological role of this natural anticoagulant mechanism. Am. J. Med. 87, 2S-9S.
34. SOUTER, P.J., THOMAS, S., HUBBARD, A.R., POOLE, S., ROMISCH, J., and GRAY, E. (2001). Antithrombin inhibits lipopolysaccharide-induced tissue factor and interleukin-6 production by mononuclear cells, human umbilical vein endothelial cells, and whole blood. Crit. Care Med. 29, 134-139.
35. STOVER, S.L., and FINE, P.R. (1987). The epidemiology and economics of spinal cord injury. Paraplegia 24, 225-228.
36. SUNOSE, Y., TAKEYOSHI, I., OHWADA, S., et al. (2001). The effect of cyclooxygenase-2 inhibitor FK3311 on ischemia-reperfusion injury in a canine total hepatic vascular exclusion model. J. Am. Coll. Surg. 192, 54-62.
37. TAOKA, Y., OKAJIMA, K., UCHIBA, M., et al. (1997a). Reduction of spinal cord injury by administration of iloprost, a stable prostacyclin analog. J. Neurosurg. 86, 1007-1011.
38. TAOKA, Y., OKAJIMA, K., UCHIBA, M., et al. (1997b). Role of neutrophils in spinal cord injury in the rat. Neuroscience 79, 1177-1182.
39. TAOKA, Y., OKAJIMA, K., MURAKAMI, K., JOHNO, M, and NARUO, M. (1998a). Role of neutrophil elastase in compression-induced spinal cord injury in rats. Brain Res. 799, 264-269.
40. TAOKA, Y., OKAJIMA, K., UCHIBA, M., et al. (1998b). Activated protein C reduces the severity of compression-induced spinal cord injury in rats by inhibiting activation of leukocytes. J. Neurosci. 18, 1393-1398.
41. TAOKA, Y., and OKAJIMA, K. (1998c). Spinal cord injury in the rat. Prog. Neurobiol. 56, 341-358.
42. TAOKA, Y., and OKAJIMA, K. (2000). Role of leukocytes in spinal cord injury in rats. J. Neurotrauma 17, 219-229.
43. TAOKA, Y., OKAJlMA, K., UCHIBA, M., and JOHNO, M. (2001). Methylprednisolone reduces spinal cord injury in rats without affecting tumor necrosis factor-α production. J. Neurotrauma 18, 533-543.
44. TAOKA, Y., and OKAJIMA, K. (2003). Neuroinflammation as an important pathogenic mechanism in spinal cord injury, in: Neuroinflammation: Mechanisms and Management, 2nd Ed. P.L. Wood (ed), Humana Press, Totowa, NJ, pps. 215-236.
45. TATOR, C.H., and FEHLINGS, M.G. (1991). Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J. Neurosurg. 75, 15-26.
46. UCHIBA, M., OKAJIMA, K., MURAKAMI, K., OKABE, H., and TAKATSUKI, K. (1996). Attenuation of endotoxin-induced pulmonary vascular injury by antithrombin III. Am. J. Physiol. 270, L921-L930.
47. UCHIBA, M., OKAJIMA, K., and MURAKAMI, K. (1998). Effects of various doses of antithrombin III on endotoxin-induced endothelial cell injury and coagulation abnormalities in rats. Thromb. Res. 89, 231-241.
48. UCHIBA, M., and OKAJIMA, K. (2001). Antithrombin does not directly promote the endothelial production of prostacyclin in cultured endothelial cells. Thromb. Haemost. 86, 722-723.
49. XU, J., HSU, C.Y., LIU, T.H., HOGAN, E.L., PEROT, E., and TAI, H. (1990). Leukotriene B4 release and polymorphonuclear cell infiltration in spinal cord injury. J. Neurochem. 55, 907-912.
50. WINKLER, T., SHARMA, H.S., STALBERG, E., and OLSSON, Y. (1993). Indomethacin, an inhibitor of prostaglandin synthesis attenuates alteration in spinal cord evoked potentials and edema formation after trauma to the spinal cord: an experimental study in the rat. Neuroscience 52, 1057-1067.
51. YAKOVLEV, A.G., and FADEN, A.I. (1994) Sequential expression of c-fos protooncogene, TNF-alpha, and dynorphin genes in spinal cord following experimental traumatic injury. Mol. Chem. Neuropathol. 23, 179-190.